Search Results - "Ivey, Melanie E"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Endothelin-1 signalling in vascular smooth muscle: Pathways controlling cellular functions associated with atherosclerosis by Ivey, Melanie E, Osman, Narin, Little, Peter J

    Published in Atherosclerosis (01-08-2008)
    “…Abstract Atherosclerosis is the primary ischaemic vascular condition underlying a majority of cardiovascular disease related deaths. Endothelin-1 is a…”
    Get full text
    Journal Article
  2. 2

    Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways by Ivey, Melanie E, Little, Peter J

    Published in Thrombosis research (01-01-2008)
    “…Abstract Introduction Atherosclerosis is the underlying pathological process of most cardiovascular disease. Thrombin is a serine protease which can activate…”
    Get full text
    Journal Article
  3. 3

    Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis by Survase, Soniya, Ivey, Melanie E, Nigro, Julie, Osman, Narin, Little, Peter J

    “…Calcium channel blockers (CCBs) are a widely used group of antihypertensive agents. CCBs are efficacious in the reduction of blood pressure but the extent to…”
    Get full text
    Journal Article
  4. 4

    Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL by Ballinger, Mandy L, Ivey, Melanie E, Osman, Narin, Thomas, Walter G, Little, Peter J

    Published in Atherosclerosis (01-08-2009)
    “…Abstract Objective Lipid retention in the vessel wall by glycosaminoglycan (GAG) chains on chondroitin/dermatan sulfate proteoglycans synthesized by vascular…”
    Get full text
    Journal Article
  5. 5

    Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis by Little, Peter J, Ivey, Melanie E, Osman, Narin

    Published in Current vascular pharmacology (01-07-2008)
    “…The formation and progression of atherosclerotic plaques followed by rupture, thrombus formation and vessel blockage leads to ischemic tissue damage and the…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents by de Dios, Stephanie T, Frontanilla, Karen V, Nigro, Julie, Ballinger, Mandy L, Ivey, Melanie E, Cawson, Elizabeth A, Little, Peter J

    Published in Journal of diabetes and its complications (01-03-2007)
    “…Abstract The present study aimed to investigate the actions of several classes of oral hypoglycemic agents [e.g., sulfonylureas (SUs), biguanides (BGs) and…”
    Get full text
    Journal Article
  8. 8

    Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells by Ballinger, Mandy L., Thomas, Merlin C., Nigro, Julie, Ivey, Melanie E., Dilley, Rodney J., Little, Peter J.

    Published in Kidney international (01-12-2005)
    “…Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. Advanced glycation end products (AGEs) accumulate in…”
    Get full text
    Journal Article
  9. 9
  10. 10